Vinblastine, vincristine, prednisone, daunorubicin ( DrugBank: Vincristine, Vinblastine, Prednisone, Daunorubicin )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
65原発性免疫不全症候群1

65. 原発性免疫不全症候群


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00187057
(ClinicalTrials.gov)
September 200212/9/2005Study for Treatment of Cancer in Children With Ataxia-telangiectasiaPilot Study I for Treatment of Cancer in Children With Ataxia-TelangiectasiaAtaxia-TelangiectasiaDrug: vinblastine, vincristine, prednisone, daunorubicin;Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase;Drug: etoposide, cytarabine, mercaptopurine;Drug: dexamethasone, procarbazine;Procedure: chemotherapy, intrathecal chemotherapy, steroid therapySt. Jude Children's Research HospitalChildren's Hospital of Philadelphia;National Cancer Institute (NCI)CompletedN/A10 YearsBoth6N/AUnited States